FindTrial
Sign In

A Prospective randomized control study to compare Levobupivacaine with Ropivacaine in ultrasound guided axillary block in distal forearm surgeries.

A Prospective randomized, comparative study between dexmedetomidine and buprenorphine as an adjuvant to 0.5% Ropivacaine in ultrasound guided supraclavicular brachial plexus block for upper limb orthopedic surgeries. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036332
Enrollment
60
Registered
2021-09-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S523- Fracture of shaft of radius Health Condition 2: S522- Fracture of shaft of ulna

Interventions

Control Intervention1: levobupivacaine: 100 mg during the administration of the block Control Intervention2: Ropivacaine: 100 mg during the adminstration of the block

Sponsors

Sanjay Gandhi Institute Of Trauma And Orthopedics
Lead Sponsor
Dr Aparna
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged between 18 to 60 years admitted for elective upper limb orthopaedic surgeries in Sanjay Gandhi Institute Of Trauma And Orthopaedics, Bengaluru. .

Exclusion criteria

Exclusion criteria: Patients with a history of significant neurological, psychiatric, neuromuscular, alcohol dependence or drug abuse and patients receiving adrenoceptor agonist or antagonist therapy.

Design outcomes

Primary

MeasureTime frame
Time of onset of sensory block and total analgesiaTimepoint: 1 day—

Secondary

MeasureTime frame
adverse reaction if anyTimepoint: 1 day—

Countries

India

Contacts

Public ContactDr Aparna B

Sanjay Gandhi Institute of Trauma And Orthopedics

appu1021@gmail.com9963296662

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026